Mylan sued over generic of blockbuster AstraZeneca asthma drug Ruling ends one West Virginia case, another goes to trial in December (Reuters) - Viatris' Mylan Pharmaceuticals Inc cleared a hurdle ...

Viatris Inc. VTRS announced that the company and partner Kindeva Drug Delivery L.P. have won a court decision that invalidates AstraZeneca's AZN patent for Symbicort. The U.S. District Court for the ...

Viatris and Kindeva Drug Delivery announced that they have won a significant court decision in which the U.S. District Court for the Northern District of West Virginia found that AstraZeneca's ...

In the courtroom fracas over the patents on AstraZeneca’s multibillion-dollar inhaler Symbicort, Viatris and Kindeva Drug Delivery have toppled yet another intellectual property pillar. Still, ...

LONDON, Oct 18 (Reuters) - AstraZeneca Plc lost a key European patent on its two-in-one asthma drug Symbicort on Thursday but the drugmaker said it did not expect the move to have an immediate impact ...

FILE PHOTO: A U.S. flag stands next to the AstraZeneca logo during a signing event for documents related to a manufacturing site investment at the Meridian International Center in Washington, D.C., ...

AstraZeneca has been reprimanded by the U.K. drug marketing authority for a series of breaches of its code of conduct across its website for its respiratory franchise. A healthcare professional in the ...

AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1.

PITTSBURGH, Nov. 10, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it and Kindeva Drug Delivery L.P. have won a significant court decision in ...